Citations (64)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Miquel Roca, Annalisa Bonelli, Agnese Cattaneo, Alessandro Comandini, Giorgio Di Dato, Franca Heiman, Valeria Pegoraro, Siegfried Kasper, Hans-Peter Volz & Diego Palao. (2023) Factors associated with sick leave duration in patients suffering from major depressive disorder initiating antidepressant treatment: a real-world evidence study in Germany and Spain. International Journal of Psychiatry in Clinical Practice 27:1, pages 59-68.
Read now
Read now
Drishti Shah, Wanhong Zheng, Lindsay Allen, Wenhui Wei, Traci LeMasters, Suresh Madhavan & Usha Sambamoorthi. (2021) Using a machine learning approach to investigate factors associated with treatment-resistant depression among adults with chronic non-cancer pain conditions and major depressive disorder. Current Medical Research and Opinion 37:5, pages 847-859.
Read now
Read now
Amna Majeed, Jiaqi Xiong, Kayla M. Teopiz, Jason Ng, Roger Ho, Joshua D. Rosenblat, Lee Phan, Bing Cao & Roger S. McIntyre. (2021) Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials. Expert Opinion on Emerging Drugs 26:1, pages 63-74.
Read now
Read now
Motoki Higashiyama, Taito Hayashida, Keisuke Sakuta, Yota Fujimura, Jiro Masuya, Masahiko Ichiki, Hajime Tanabe, Ichiro Kusumi & Takeshi Inoue. (2019) Complex effects of childhood abuse, affective temperament, and subjective social status on depressive symptoms of adult volunteers from the community. Neuropsychiatric Disease and Treatment 15, pages 2477-2485.
Read now
Read now
Dena H Jaffe, Benoit Rive & Tom R Denee. (2019) The burden of suicidal ideation across Europe: a cross-sectional survey in five countries. Neuropsychiatric Disease and Treatment 15, pages 2257-2271.
Read now
Read now
Kai Yao, Yong-fei Zhao & Heng-bing Zu. (2019) Melatonin receptor stimulation by agomelatine prevents Aβ-induced tau phosphorylation and oxidative damage in PC12 cells. Drug Design, Development and Therapy 13, pages 387-396.
Read now
Read now
Ashish Dhir. (2017) Investigational drugs for treating major depressive disorder. Expert Opinion on Investigational Drugs 26:1, pages 9-24.
Read now
Read now
Qunlian Huang, Xiaoyan Zhong, Ye Yun, Bin Yu & Yilan Huang. (2016) Efficacy and safety of multiple doses of levomilnacipran extended-release for the treatment of major depressive disorder. Neuropsychiatric Disease and Treatment 12, pages 2707-2714.
Read now
Read now
Pao-Yen Lin. (2015) Regulation of proteolytic cleavage of brain-derived neurotrophic factor precursor by antidepressants in human neuroblastoma cells. Neuropsychiatric Disease and Treatment 11, pages 2529-2532.
Read now
Read now
Blanka Kores Plesničar. (2014) Efficacy and tolerability of agomelatine in the treatment of depression. Patient Preference and Adherence 8, pages 603-612.
Read now
Read now
Edoardo Spina & Jose de Leon. (2014) Clinically relevant interactions between newer antidepressants and second-generation antipsychotics. Expert Opinion on Drug Metabolism & Toxicology 10:5, pages 721-746.
Read now
Read now
Jan Pecenak. (2013) Agomelatine as monotherapy for major depression: an outpatient, open-label study. Neuropsychiatric Disease and Treatment 9, pages 1595-1604.
Read now
Read now
Articles from other publishers (52)
Ping Guo, Yong Xu, Liang Lv, Min Feng, Yu Fang, Wei-Quan Huang, Shan-Fei Cheng, Min-Cai Qian, Shengliang Yang, Shi-Kai Wang & Huan-Xin Chen. (2023) A multicenter, randomized controlled study on the efficacy of agomelatine in ameliorating anhedonia, reduced motivation, and circadian rhythm disruptions in patients with major depressive disorder (MDD). Annals of General Psychiatry 22:1.
Crossref
Crossref
Yue-Han Guo, Le Zhou, Zi-Ang Cui, Jian Wang, Lei Zhang, Ting Xu, Yi-Dan XieHui Chen. (2023) Efficacy and safety of agomelatine in the treatment of patients with depressive disorder: A meta-analysis. Medicine 102:45, pages e35871.
Crossref
Crossref
Vasilios G. Masdrakis, Manolis Markianos & David S. Baldwin. (2023) Apathy associated with antidepressant drugs: a systematic review. Acta Neuropsychiatrica 35:4, pages 189-204.
Crossref
Crossref
Zhe Li, Ting-Ting Wu, Yi-Ting Xiong, Xin-Yang Zhang, Yan-Ping Bao, Li-Bo Guo, Bao-Jie Han, Su-Xia Li, Yu-Feng Wang, Lin Lu & Xue-Qin Wang. (2023) A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine. Frontiers in Psychiatry 14.
Crossref
Crossref
Emily M. Bartholomay, Bryant M. Stone & Grace A. Lyons. (2021) Depression and social anxiety symptoms explain substance use problems beyond amount/frequency of substance use. Current Psychology 42:8, pages 6249-6256.
Crossref
Crossref
Bruna R. Kouba, Ana Clara N. C. Torrá, Anderson Camargo & Ana Lúcia S. Rodrigues. (2022) The antidepressant-like effect elicited by vitamin D3 is associated with BDNF/TrkB-related synaptic protein synthesis. Metabolic Brain Disease 38:2, pages 601-611.
Crossref
Crossref
Chloe E. Wilson, Jacob J. Crouse, Joanne S. Carpenter & Ian B. Hickie. 2023. Encyclopedia of Sleep and Circadian Rhythms. Encyclopedia of Sleep and Circadian Rhythms
766
779
.
Mikhail Zastrozhin, Valentin Skryabin, Aleksey Petukhov, Elena Pankratenko, Sergei Pozdniakov, Valentina Ivanchenko, Denis Horyaev, Roman Vlasovskih, Evgeny Bryun & Dmitry Sychev. (2022)
Effects of
CYP2D6*4
polymorphism on the steady-state concentration of paroxetine in patients diagnosed with depressive episode and comorbid alcohol use disorder
. Journal of Psychopharmacology 36:10, pages 1146-1150.
Crossref
Crossref
Maya Amitai, Shaked Kaffman, Eitan Kroizer, Maya Lebow, Iddo Magen, Noa Benaroya-Milshtein, Silvana Fennig, Abraham Weizman, Alan Apter & Alon Chen. (2022) Neutrophil to-lymphocyte and platelet-to-lymphocyte ratios as biomarkers for suicidal behavior in children and adolescents with depression or anxiety treated with selective serotonin reuptake inhibitors. Brain, Behavior, and Immunity 104, pages 31-38.
Crossref
Crossref
Yadeta Alemayehu, Henock Asfaw & Million Girma. (2022) Magnitude and factors associated with treatment non-adherence among patients with depressive disorders at St. Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia, 2019: A cross sectional study. PLOS ONE 17:7, pages e0271713.
Crossref
Crossref
Marco Aurélio Cigognini, Alia Garrudo Guirado, Denise van de Meene, Mônica Andréia Schneider, Mônica Sarah Salomon, Vinicius Santana de Alexandria, Juliana Pisseta Adriano, Ana Maria Thaler, Fernando dos Santos Fernandes, Adriana Carneiro & Ricardo Alberto Moreno. (2022) Intramuscular ketamine vs. escitalopram and aripiprazole in acute and maintenance treatment of patients with treatment-resistant depression: A randomized double-blind clinical trial. Frontiers in Psychiatry 13.
Crossref
Crossref
Chaoyou Fang, Zeyu Zhang, Houshi Xu, Yibo Liu, Xiaoyu Wang, Ling Yuan, Yuanzhi Xu, Zhengyang Zhu, Anke Zhang, Anwen Shao & Meiqing Lou. (2022) Natural Products for the Treatment of Post-stroke Depression. Frontiers in Pharmacology 13.
Crossref
Crossref
Kouji Fukuyama, Eishi Motomura, Takashi Shiroyama & Motohiro Okada. (2022) Impact of 5-HT7 receptor inverse agonism of lurasidone on monoaminergic tripartite synaptic transmission and pathophysiology of lower risk of weight gain. Biomedicine & Pharmacotherapy 148, pages 112750.
Crossref
Crossref
Vilma Liaugaudaite, Nijole Raskauskiene, Rima Naginiene, Narseta Mickuviene & Leo Sher. (2022) Association between lithium levels in drinking water and suicide rates: Role of affective disorders. Journal of Affective Disorders 298, pages 516-521.
Crossref
Crossref
Tian Lan, Ya-Qing Ma, Ya-Min Dang, Chen-Chen Wang, Ren-Ai Xu, Jian-Ping Cai & Guo-Xin Hu. (2021) Effects of 31 recombinant CYP2C19 variants on clomipramine metabolism in vitro. Journal of Psychopharmacology 35:12, pages 1517-1522.
Crossref
Crossref
Gianluca Serafini, Alice Trabucco, Giovanni Corsini, Andrea Escelsior, Andrea Amerio, Andrea Aguglia, Henry Nasrallah & Mario Amore. (2021) The potential of microRNAs as putative biomarkers in major depressive disorder and suicidal behavior. Biomarkers in Neuropsychiatry 5, pages 100035.
Crossref
Crossref
Caroline Zangani, Barbara Giordano, Hans‐Christian Stein, Stefano Bonora, Armando D'Agostino & Edoardo Giuseppe Ostinelli. (2021) Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta‐analysis. Human Psychopharmacology: Clinical and Experimental 36:6.
Crossref
Crossref
Abd El Kader Ait Tayeb, Romain Colle, Khalil El-Asmar, Kenneth Chappell, Cécile Acquaviva-Bourdain, Denis J. David, Séverine Trabado, Philippe Chanson, Bruno Feve, Laurent Becquemont, Céline Verstuyft & Emmanuelle Corruble. (2021)
Plasma acetyl-
l
-carnitine and
l
-carnitine in major depressive episodes: a case–control study before and after treatment
. Psychological Medicine, pages 1-10.
Crossref
Crossref
Beata Łebkowska-Wieruszewska, Hubert Ziółkowski, Irene Sartini, Andrzej Lisowski, Cezary J. Kowalski, Amnart Poapolathep & Mario Giorgi. (2021) Agomelatine: A novel melatonergic antidepressant. Method validation and first exploratory pharmacokinetic study in fasted and fed dogs. Research in Veterinary Science 139, pages 140-144.
Crossref
Crossref
Lauren Allen McKibben & Yogesh Dwivedi. (2021) MicroRNA Regulates Early-Life Stress–Induced Depressive Behavior via Serotonin Signaling in a Sex-Dependent Manner in the Prefrontal Cortex of Rats. Biological Psychiatry Global Open Science 1:3, pages 180-189.
Crossref
Crossref
Nan Zhang, Lihua Yao, Peilin Wang & Zhongchun Liu. (2021) Immunoregulation and antidepressant effect of ketamine. Translational Neuroscience 12:1, pages 218-236.
Crossref
Crossref
Yachen Shi, Ruize Song, Zan Wang, Hongxing Zhang, Jianli Zhu, Yuanping Yue, Yang Zhao & Zhijun Zhang. (2021) Potential clinical value of circular RNAs as peripheral biomarkers for the diagnosis and treatment of major depressive disorder. eBioMedicine 66, pages 103337.
Crossref
Crossref
Gianluca Serafini, Matteo Pardini, Fiammetta Monacelli, Beatrice Orso, Nicola Girtler, Andrea Brugnolo, Mario Amore, Flavio Nobili & Disease Management Team on Dementia of the IRCCS Ospedale Policlinico San Martino. (2021) Neuroprogression as an Illness Trajectory in Bipolar Disorder: A Selective Review of the Current Literature. Brain Sciences 11:2, pages 276.
Crossref
Crossref
Gianluca Serafini, Gustavo Vazquez, Fiammetta Monacelli, Matteo Pardini, Maurizio Pompili & Mario Amore. (2021) The use of antidepressant medications for Bipolar I and II disorders. Psychiatry Research 296, pages 113273.
Crossref
Crossref
Nicholas M. Barnes, Gerard P. Ahern, Carine Becamel, Joël Bockaert, Michael Camilleri, Severine Chaumont-Dubel, Sylvie Claeysen, Kathryn A. Cunningham, Kevin C. Fone, Michael Gershon, Giuseppe Di Giovanni, Nathalie M. Goodfellow, Adam L. Halberstadt, Rachel M. Hartley, Ghérici Hassaine, Katharine Herrick-Davis, Ruud Hovius, Enza Lacivita, Evelyn K. Lambe, Marcello Leopoldo, Finn Olav Levy, Sarah C. R. Lummis, Philippe Marin, Luc Maroteaux, Andrew C. McCreary, David L. Nelson, John F. Neumaier, Adrian Newman-Tancredi, Hugues Nury, Alexander Roberts, Bryan L. Roth, Anne Roumier, Gareth J. Sanger, Milt Teitler, Trevor Sharp, Carlos M. Villalón, Horst Vogel, Stephanie W. Watts & Daniel Hoyer. (2020) International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacological Reviews 73:1, pages 310-520.
Crossref
Crossref
Renqiang Yu, Huan Tan, Gang Peng, Lian Du, Peijia Wang, Zhiwei Zhang & Fajin Lyu. (2021) Anomalous functional connectivity within the default-mode network in treatment-naive patients possessing first-episode major depressive disorder. Medicine 100:23, pages e26281.
Crossref
Crossref
Anderson Camargo, Ana Paula Dalmagro, Márcia M. de Souza, Ana Lúcia B. Zeni & Ana Lúcia S. Rodrigues. (2020) Ketamine, but not guanosine, as a prophylactic agent against corticosterone-induced depressive-like behavior: Possible role of long-lasting pro-synaptogenic signaling pathway. Experimental Neurology 334, pages 113459.
Crossref
Crossref
Gianluca Serafini, Xenia Gonda, Giovanna Canepa, Pierre A. Geoffroy, Maurizio Pompili & Mario Amore. (2020) Recent Stressful Life Events in Euthymic Major Depressive Disorder Patients: Sociodemographic and Clinical Characteristics. Frontiers in Psychiatry 11.
Crossref
Crossref
Enrico Moretti, Gaia Favero, Luigi Fabrizio Rodella & Rita Rezzani. (2020) Melatonin’s Antineoplastic Potential Against Glioblastoma. Cells 9:3, pages 599.
Crossref
Crossref
S. K. Gruzdev, A. A. Yakovlev, T. A. Druzhkova, A. B. Guekht & N. V. Gulyaeva. (2019) The Missing Link: How Exosomes and miRNAs can Help in Bridging Psychiatry and Molecular Biology in the Context of Depression, Bipolar Disorder and Schizophrenia. Cellular and Molecular Neurobiology 39:6, pages 729-750.
Crossref
Crossref
Katharina I. Salo, Jana Scharfen, Isabelle D. Wilden, Ricarda I. Schubotz & Heinz Holling. (2019) Confining the Concept of Vascular Depression to Late-Onset Depression: A Meta-Analysis of MRI-Defined Hyperintensity Burden in Major Depressive Disorder and Bipolar Disorder. Frontiers in Psychology 10.
Crossref
Crossref
Özgür Can, Umut Üçel, Ümide Demir Özkay & Emel Ulupınar. (2018) The Effect of Agomelatine Treatment on Diabetes-Induced Cognitive Impairments in Rats: Concomitant Alterations in the Hippocampal Neuron Numbers. International Journal of Molecular Sciences 19:8, pages 2461.
Crossref
Crossref
Timothy R Powell, Tytus Murphy, Sang H Lee, Jack Price, Sandrine Thuret & Gerome Breen. (2017) Transcriptomic profiling of human hippocampal progenitor cells treated with antidepressants and its application in drug repositioning. Journal of Psychopharmacology 31:3, pages 338-345.
Crossref
Crossref
Andreas Walther, Timothy Rice, Yael Kufert & Ulrike Ehlert. (2017) Neuroendocrinology of a Male-Specific Pattern for Depression Linked to Alcohol Use Disorder and Suicidal Behavior. Frontiers in Psychiatry 7.
Crossref
Crossref
Thomas Sobanski & Gerd Wagner. (2017) Functional neuroanatomy in panic disorder: Status quo of the research. World Journal of Psychiatry 7:1, pages 12.
Crossref
Crossref
S. Teng, Z. Guo, H. Peng, G. Xing, H. Chen, B. He, M.A. McClure & Q. Mu. (2017) High-frequency repetitive transcranial magnetic stimulation over the left DLPFC for major depression: Session-dependent efficacy: A meta-analysis. European Psychiatry 41:1, pages 75-84.
Crossref
Crossref
Sundus Khalid, Claire M. Williams & Shirley A. Reynolds. (2017) Is there an association between diet and depression in children and adolescents? A systematic review. British Journal of Nutrition 116:12, pages 2097-2108.
Crossref
Crossref
Wigdan H Farah, Mouaz Alsawas, Maria Mainou, Fares Alahdab, Magdoleen H Farah, Ahmed T Ahmed, Essa A Mohamed, Jehad Almasri, Michael R Gionfriddo, Ana Castaneda-Guarderas, Khaled Mohammed, Zhen Wang, Noor Asi, Craig N Sawchuk, Mark D Williams, Larry J Prokop, M Hassan Murad & Annie LeBlanc. (2016) Non-pharmacological treatment of depression: a systematic review and evidence map. Evidence Based Medicine 21:6, pages 214-221.
Crossref
Crossref
Dongxue Yang, Wenbo Zhang, Arshad Padhiar, Yao Yue, Yonghui Shi, Tiezheng Zheng, Kaspar Davis, Yu Zhang, Min Huang, Yuyuan Li & Li Sha. (2016) NPAS3 Regulates Transcription and Expression of VGF: Implications for Neurogenesis and Psychiatric Disorders. Frontiers in Molecular Neuroscience 9.
Crossref
Crossref
Hang Xu, Yu Zhang, Fan Zhang, San-na Yuan, Feng Shao & Weiwen Wang. (2016) Effects of Duloxetine Treatment on Cognitive Flexibility and BDNF Expression in the mPFC of Adult Male Mice Exposed to Social Stress during Adolescence. Frontiers in Molecular Neuroscience 9.
Crossref
Crossref
Clara Herrera-Arozamena, Olaia Martí-Marí, Martín Estrada, Mario de la Fuente Revenga & María Rodríguez-Franco. (2016) Recent Advances in Neurogenic Small Molecules as Innovative Treatments for Neurodegenerative Diseases. Molecules 21:9, pages 1165.
Crossref
Crossref
Vesile Altınyazar & Nefati Kiylioglu. (2016) Insomnia and dementia: is agomelatine treatment helpful? Case report and review of the literature. Therapeutic Advances in Psychopharmacology 6:4, pages 263-268.
Crossref
Crossref
Aline Haas de Mello, Luana da Rosa Souza, Ana Carla Moreira Cereja, Rosiane de Bona Schraiber, Drielly Florentino, Maryane Modolon Martins, Fabricia Petronilho, João Quevedo & Gislaine Tezza Rezin. (2016) Effect of subchronic administration of agomelatine on brain energy metabolism and oxidative stress parameters in rats. Psychiatry and Clinical Neurosciences 70:4, pages 159-166.
Crossref
Crossref
Sang Jeon & Yong-Ku Kim. (2016) Molecular Neurobiology and Promising New Treatment in Depression. International Journal of Molecular Sciences 17:3, pages 381.
Crossref
Crossref
Ilaria Callegari, Chiara Mattei, Francesca Benassi, Frank Krueger, Jordan Grafman, Özgür Yaldizli, Davide Sassos, Davide Massucco, Carlo Scialò, Flavio Nobili, Carlo Serrati, Mario Amore, Leonardo Cocito, Leonardo Emberti Gialloreti & Matteo Pardini. (2016) Agomelatine Improves Apathy in Frontotemporal Dementia. Neurodegenerative Diseases 16:5-6, pages 352-356.
Crossref
Crossref
Yanling She, Jian Xu, Yanhong Duan, Ning Su, Yanan Sun, Xiaohua Cao, Lixing Lao, Ruixin Zhang & Shifen Xu. (2015) Possible antidepressant effects and mechanism of electroacupuncture in behaviors and hippocampal synaptic plasticity in a depression rat model. Brain Research 1629, pages 291-297.
Crossref
Crossref
David Baumeister, Luis M. Tojo & Derek K. Tracy. (2015) Legal highs: staying on top of the flood of novel psychoactive substances. Therapeutic Advances in Psychopharmacology 5:2, pages 97-132.
Crossref
Crossref
Domenico De Berardis, Michele Fornaro, Nicola Serroni, Daniela Campanella, Gabriella Rapini, Luigi Olivieri, Venkataramanujam Srinivasan, Felice Iasevoli, Carmine Tomasetti, Andrea De Bartolomeis, Alessandro Valchera, Giampaolo Perna, Monica Mazza, Marco Di Nicola, Giovanni Martinotti & Massimo Di Giannantonio. (2015) Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression. International Journal of Molecular Sciences 16:1, pages 1111-1130.
Crossref
Crossref
M. Pardini, C. Cordano, F. Benassi, C. Mattei, D. Sassos, S. Guida, C. Serrati, A. Primavera, M. Amore, L. Cocito & L. Emberti Gialloreti. (2014) Agomelatine but not melatonin improves fatigue perception: A longitudinal proof-of-concept study. European Neuropsychopharmacology 24:6, pages 939-944.
Crossref
Crossref
Caroline Caddy, Giovanni Giaroli, Thomas P. White, Sukhwinder S. Shergill & Derek K. Tracy. (2013) Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy. Therapeutic Advances in Psychopharmacology 4:2, pages 75-99.
Crossref
Crossref
Krzysztof Wędzony, Agnieszka Chocyk & Marzena Maćkowiak. (2013) Potential roles of NCAM/PSA-NCAM proteins in depression and the mechanism of action of antidepressant drugs. Pharmacological Reports 65:6, pages 1471-1478.
Crossref
Crossref
Domenico De Berardis, Stefano Marini, Michele Fornaro, Venkataramanujam Srinivasan, Felice Iasevoli, Carmine Tomasetti, Alessandro Valchera, Giampaolo Perna, Maria-Antonia Quera-Salva, Giovanni Martinotti & Massimo di Giannantonio. (2013) The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice. International Journal of Molecular Sciences 14:6, pages 12458-12483.
Crossref
Crossref